The global artificial vital organs and medical bionics market is expected to grow at a CAGR of 8.2% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases. These chronic diseases are leading to an increase in demand for artificial vital organs and medical bionics devices.
The global artificial vital organs and medical bionics market is segmented on the basis of type into artificial vital organs and medical bionics devices. Artificial vital organs are further classified into mechanical heart pumps, ventricular assist devices (VADs), left ventricular assist device (LVADs), right ventricular assist device (RVADs), total artificial hearts, implantable blood pumps, implantable dialysis machines, implantable oxygenators/oxygenators-pumps-ventilators (O2PVs) or extracorporeal membrane oxygenation systems (ECMO). Medical bionics devices are classified into prosthetic limbs or limbs with myoelectric control system; prosthetic hands with myoelectric control system; prosthetic feet with myoelectric control system; orthotic braces for lower extremities; orthotic braces for upper extremities; orthotic braces for spine/torso; orthotic braces for neck/head/jaw; other types of orthotics including custom made products such as custom made shoes or custom made gloves etc; other types of implants including dental implants etc; other types of surgical instruments including surgical lasers etc; other types which include hearing aids etc, neurostimulators such as deep brain stimulators etc, pacemakers like cardiac pacemakers or neurostimulators like deep brain stimulators etc, intraocular lenses like corneal inlay lenses or intraocular lenses that can be implanted inside eye ball cavity called phakic IOLs that can be used in cataract surgery patients who have had previous cataract surgery but still need glasses after cataract surgery because they have developed presbyopia due to age related changes in their lens inside eye ball cavity called aphakia.
North America dominates the global artificial vital organs and medical bionics market owing to high adoption rates among hospitals due to increasing prevalence rates among chronic diseases such as diabetes, cancer, cardiovascular disease which leads to an increase in demand for these products across North America region.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the growth of the global Artificial Vital Organs and Medical Bionics market.
- Rising geriatric population base in developed countries such as North America and Europe is also driving the growth of this market.
- Increasing awareness about artificial organs among people in developing countries such as India and China is also contributing to the growth of this market.
- Technological advancements in medical bionics are expected to fuel the growth of this market.
Industry Growth Insights published a new data on “Artificial Vital Organs and Medical Bionics Market”. The research report is titled “Artificial Vital Organs and Medical Bionics Market research by Types (Artificial Vital Organs, Bionics, ), By Applications (Hospitals, Clinics, Others, ), By Players/Companies Abbott, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter, Cyberonics, Inc., Edwards, Ekso Bionics, Roche, Fresenius, Baxter International, Iwalk, Jarvik Heart, Medtronic, Micromed Cardiovascular, Nikkiso, Ossur Hf, Ottobock, Second Sight Medical Products, Inc., Syncardia Systems, Inc., Thoratec Corporation, Touch Bionics, Inc., Vital Therapies, Inc., WorldHeart Corporation”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Vital Organs and Medical Bionics Market Research Report
By Type
Artificial Vital Organs, Bionics,
By Application
Hospitals, Clinics, Others,
By Companies
Abbott, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter, Cyberonics, Inc., Edwards, Ekso Bionics, Roche, Fresenius, Baxter International, Iwalk, Jarvik Heart, Medtronic, Micromed Cardiovascular, Nikkiso, Ossur Hf, Ottobock, Second Sight Medical Products, Inc., Syncardia Systems, Inc., Thoratec Corporation, Touch Bionics, Inc., Vital Therapies, Inc., WorldHeart Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Vital Organs and Medical Bionics Market Report Segments:
The global Artificial Vital Organs and Medical Bionics market is segmented on the basis of:
Types
Artificial Vital Organs, Bionics,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Abiomed, Inc.
- Asahi Kasei Medical Co., Ltd.
- Baxter
- Cyberonics, Inc.
- Edwards
- Ekso Bionics
- Roche
- Fresenius
- Baxter International
- Iwalk
- Jarvik Heart
- Medtronic
- Micromed Cardiovascular
- Nikkiso
- Ossur Hf
- Ottobock
- Second Sight Medical Products, Inc.
- Syncardia Systems, Inc.
- Thoratec Corporation
- Touch Bionics, Inc.
- Vital Therapies, Inc.
- WorldHeart Corporation
Highlights of The Artificial Vital Organs and Medical Bionics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Vital Organs
- Bionics
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Vital Organs and Medical Bionics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial vital organs are devices that are implanted into a human body to replace a damaged or missing organ. Medical bionics is the use of technology to improve the function of biological systems, such as the heart, lungs, and muscles.
Some of the major players in the artificial vital organs and medical bionics market are Abbott, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter, Cyberonics, Inc., Edwards, Ekso Bionics, Roche, Fresenius, Baxter International, Iwalk, Jarvik Heart, Medtronic, Micromed Cardiovascular, Nikkiso, Ossur Hf, Ottobock, Second Sight Medical Products, Inc., Syncardia Systems, Inc., Thoratec Corporation, Touch Bionics, Inc., Vital Therapies, Inc., WorldHeart Corporation.
The artificial vital organs and medical bionics market is expected to register a CAGR of 8.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Vital Organs and Medical Bionics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Vital Organs and Medical Bionics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Vital Organs and Medical Bionics Market - Supply Chain
4.5. Global Artificial Vital Organs and Medical Bionics Market Forecast
4.5.1. Artificial Vital Organs and Medical Bionics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Vital Organs and Medical Bionics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Artificial Vital Organs and Medical Bionics Market Absolute $ Opportunity
5. Global Artificial Vital Organs and Medical Bionics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
5.3.1. Artificial Vital Organs
5.3.2. Bionics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Artificial Vital Organs and Medical Bionics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Artificial Vital Organs and Medical Bionics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Artificial Vital Organs and Medical Bionics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Artificial Vital Organs and Medical Bionics Demand Share Forecast, 2019-2026
9. North America Artificial Vital Organs and Medical Bionics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
9.7.1. Artificial Vital Organs
9.7.2. Bionics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Artificial Vital Organs and Medical Bionics Demand Share Forecast, 2019-2026
10. Latin America Artificial Vital Organs and Medical Bionics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
10.7.1. Artificial Vital Organs
10.7.2. Bionics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Artificial Vital Organs and Medical Bionics Demand Share Forecast, 2019-2026
11. Europe Artificial Vital Organs and Medical Bionics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
11.7.1. Artficial Vital Organs
11.7.2. Bionics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Artificial Vital Organs and Medical Bionics Demand Share, 2019-2026
12. Asia Pacific Artificial Vital Organs and Medical Bionics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
12.7.1. Artificial Vital Organs
12.7.2. Bionics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Artificial Vital Organs and Medical Bionics Demand Share, 2019-2026
13. Middle East & Africa Artificial Vital Organs and Medical Bionics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size and Volume Forecast by Type
13.7.1. Artificial Vital Organs
13.7.2. Bionics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Artificial Vital Organs and Medical Bionics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Artificial Vital Organs and Medical Bionics Market: Market Share Analysis
14.2. Artificial Vital Organs and Medical Bionics Distributors and Customers
14.3. Artificial Vital Organs and Medical Bionics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abiomed, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Asahi Kasei Medical Co., Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Baxter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cyberonics, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Edwards
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ekso Bionics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fresenius
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Baxter International
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Iwalk
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Jarvik Heart
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Medtronic
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Micromed Cardiovascular
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Nikkiso
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Ossur Hf
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Ottobock
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Second Sight Medical Products, Inc.
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Syncardia Systems, Inc.
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Thoratec Corporation
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
